Motley Fool Australia

Ebos Group Ltd (ASX: EBO) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $4.24 billion
P/E Ratio 23.92
Dividend Yield 2.68%
Shares Outstanding 164.14 million
Earnings per share 1.157
Dividend per share 0.70
Year To Date Return -3.44%
Earnings Yield 4.18%
Franking N/A

Ebos Group Limited (ASX: EBO) Latest News

best asx share price dividend growth represented by fingers walking along growing piles of coins upgrade

EBOS (ASX:EBO) share price on watch after dividend surge

More »

ASX 200

ASX 200 rose 1.6%

More »

3 asx shares to buy depicted by man holding up hand with 3 fingers up

3 top ASX share picks for 2021 from NZ brokers

More »

pharmaceutical shares

EBOS share price dips on slow FY19 earnings growth

More »

5 things to watch on the ASX on Thursday

More »

The 3 stocks with the biggest increase in short-selling interest over the week

More »

fall, take hit, punch, boxing

Are these beaten down ASX shares too cheap to ignore?

More »

Why these 4 ASX shares are starting the week on a high

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Ebos Group Ltd (ASX: EBO)

EBOS is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale marginsfor PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, EBOS operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments run at 5% and 8% of revenue respectively but due to the unregulated nature are higher-margin operations.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
02 Mar 2021 $25.82 $-0.72 -2.71% 2,339 $26.91 $26.98 $25.82
01 Mar 2021 $26.54 $0.70 2.71% 4,189 $25.82 $26.54 $25.82
26 Feb 2021 $25.84 $-0.71 -2.67% 1,071 $26.50 $26.50 $25.56
25 Feb 2021 $26.55 $0.37 1.41% 34,951 $26.25 $26.59 $26.25
24 Feb 2021 $26.18 $-0.19 -0.72% 4,031 $26.73 $27.23 $26.18
23 Feb 2021 $26.37 $0.43 1.66% 2,698 $25.60 $27.09 $25.60
22 Feb 2021 $25.94 $-1.11 -4.10% 10,500 $26.74 $26.74 $25.65
19 Feb 2021 $27.05 $0.04 0.15% 4,278 $27.24 $27.26 $26.68
18 Feb 2021 $27.01 $-0.56 -2.03% 6,240 $27.50 $27.57 $26.99
17 Feb 2021 $27.57 $0.57 2.11% 10,954 $27.75 $27.75 $27.00
16 Feb 2021 $27.00 $-0.47 -1.71% 3,648 $27.50 $27.50 $27.00
15 Feb 2021 $27.47 $-0.13 -0.47% 2,560 $27.53 $27.58 $27.47
12 Feb 2021 $27.60 $-0.10 -0.36% 4,190 $27.65 $27.73 $27.60
11 Feb 2021 $27.70 $-0.30 -1.07% 24,745 $27.77 $27.81 $27.70
10 Feb 2021 $28.00 $-0.30 -1.06% 55,077 $27.87 $28.30 $27.71
09 Feb 2021 $28.30 $0.30 1.07% 3,718 $28.00 $28.30 $27.70
08 Feb 2021 $28.00 $0.30 1.08% 625 $28.50 $28.50 $27.98
05 Feb 2021 $27.70 $0.10 0.36% 3,129 $27.64 $27.72 $27.51
04 Feb 2021 $27.60 $0.10 0.36% 3,341 $27.71 $27.77 $27.53
03 Feb 2021 $27.50 $0.59 2.19% 2,310 $27.30 $27.50 $27.30
02 Feb 2021 $26.91 $0.20 0.75% 1,624 $27.32 $27.38 $26.91
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Oct 2020 Elizabeth(Liz) Coutts Issued 561 $13,306
09 Oct 2020 Sarah Ottrey Issued 104 $2,466
09 Oct 2020 Stuart McLauchlan Issued 34 $806
27 Aug 2020 Nicholas (Nick) Dowling Buy 1 $33,864
03 Apr 2020 Elizabeth(Liz) Coutts Issued 448 $9,076
03 Apr 2020 Stuart McLauchlan Issued 37 $749
03 Apr 2020 Sarah Ottrey Issued 112 $2,269
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Ms Elizabeth(Liz) Mary Coutts Non-Executive Director,Non-Executive Chairman Nov 2013
Mr Stuart James McGregor Non-Executive Director Nov 2013
Ms Sarah Christine Ottrey Non-Executive Director Nov 2013
Mr Stuart McLauchlan Non-Executive Director Jul 2019
Mr Peter Williams Non-Executive Director Nov 2013
Mr Nicholas (Nick) John Dowling Non-Executive Director Feb 2020
Mr John Cullity Chief Executive Officer Jul 2014
John Cullity Chief Executive Officer
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Sybos Holdings Pte Limited 30,525,721 18.74%
Hsbc Nominees (New Zealand) Limited – Nzcsd Hkbn90 13,881,061 8.52%
Citibank Nominees (New Zealand) Limited – Nzcsd Cnom90 9,275,939 5.70%
Jp Morgan Chase Bank Na Nz Branch-Segregated Clients Acct – Nzcsd Cham24 8,621,230 5.29%
Forsyth Barr Custodians Limited 1 – Custody 6,126,404 3.76%
Accident Compensation Corporation – Nzcsd Acci40 6,020,540 3.70%
Jp Morgan Nominees Australia Limited 4,336,788 2.66%
Custodial Services Limited A/C 4 3,963,154 2.43%
Fnz Custodians Limited 3,890,843 2.39%
National Nominees New Zealand Limited – Nzcsd Nnlz90 3,594,337 2.21%
Tea Custodians Limited Client Property Trust Account – Nzcsd Teac40 3,304,546 2.03%
Bnp Paribas Nominees (Nz) Limited – Nzcsd Cogn40 3,163,120 1.94%
Bnp Paribas Nominees (Nz) Limited – Nzcsd Bpss40 3,054,660 1.88%
Custodial Services Limited A/C 3 3,038,930 1.87%
Hsbc Nominees (New Zealand) Limited A/C State Street – Nzcsd Hkbn45 2,834,923 1.74%
Hsbc Nominees A/C New Zealand Superannuation Fund Nominees Limited 2,233,229 1.37%
HSBC Custody Nominees (Australia) Limited 2,073,350 1.27%
Custodial Services Limited A/C 2 1,851,791 1.14%
New Zealand Depository Nominee Limited A/C 1 Cash Account 1,845,546 1.13%
Whyte Adder No 3 Limited 1,796,425 1.11%
Show more